VNDA - Vanda Pharmaceuticals jumps 38% on Future Pak's latest buy offer
2024-04-17 06:41:35 ET
More on Vanda Pharmaceuticals
- Vanda Pharmaceuticals: Fanapt Bipolar Win Doesn't Change Much
- Vanda Pharmaceuticals' Portfolio Likely Has Upside From 2024 Approvals, Underpinned By Cash
- Vanda stock jumps as FDA approves Fanapt tablets for bipolar disorder
- Vanda drops as FDA rejects Hetlioz label expansion